{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:50:53Z","timestamp":1793141453563,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05137-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:04:49Z","timestamp":1751418289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Effects of piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded chitosan coated solid lipid nanoparticles in rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Indu","family":"Raghunath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Koland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprit D.","family":"Saoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-2953","authenticated-orcid":false,"given":"Sarad Pawar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Shridhar","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Rarokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar","family":"Thalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"5137_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2230-973X.176456","volume":"6","author":"R Shah","year":"2016","unstructured":"Shah, R., Patel, M., Maahs, D. & Shah, V. Insulin delivery methods: past, present and future. Int. J. Pharm. Investig. 6, 1 (2016).","journal-title":"Int. J. Pharm. Investig"},{"key":"5137_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18203\/2319-2003.ijbcp20170313","volume":"6","author":"SK Rahman","year":"2017","unstructured":"Rahman, S. K. & Kawatra, P. Insulin delivery: what is new in the queue? Int. J. Basic. Clin. Pharmacol. 6, 229 (2017).","journal-title":"Int. J. Basic. Clin. Pharmacol."},{"key":"5137_CR3","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1097\/MJT.0000000000001076","volume":"27","author":"S Cernea","year":"2020","unstructured":"Cernea, S. & Raz, I. Insulin therapy: future perspectives. Am. J. Ther. 27, E121\u2013E132 (2020).","journal-title":"Am. J. Ther."},{"key":"5137_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4239\/wjd.v7.i17.354","volume":"7","author":"JJ Mar\u00edn-Pe\u00f1alver","year":"2016","unstructured":"Mar\u00edn-Pe\u00f1alver, J. J., Mart\u00edn-Tim\u00f3n, I., Sevillano-Collantes, C. & Ca\u00f1izo-G\u00f3mez, F. J. del. Update on the treatment of type 2 diabetes mellitus. World J. Diabetes. 7, 354 (2016).","journal-title":"World J. Diabetes"},{"key":"5137_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4140\/TCP.n.2017.190","volume":"32","author":"JY Wick","year":"2017","unstructured":"Wick, J. Y. & Insulin Almost a century of lifesaving. Consult Pharm. 32, 190\u2013200 (2017).","journal-title":"Consult Pharm."},{"key":"5137_CR6","first-page":"25","volume":"5","author":"S George","year":"2013","unstructured":"George, S. & Roy, A. Novel approaches in insulin drug Delivery - A review. Int. J. Drug Dev. Res. 5, 25\u201329 (2013).","journal-title":"Int. J. Drug Dev. Res."},{"key":"5137_CR7","unstructured":"Articles, O. Hypoglycemic effect of insulin-loaded hydrogel-nanogel composite on streptozotocin-induced diabetic rats. 76, 364\u2013371 (2021)."},{"key":"5137_CR8","doi-asserted-by":"crossref","unstructured":"Ndisang, J. F., Vannacci, A. & Rastogi, S. Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017. J. Diabetes Res. 10\u201313 (2017). (2017).","DOI":"10.1155\/2017\/1478294"},{"key":"5137_CR9","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.2174\/1381612821666150710145753","volume":"21","author":"M Meneses","year":"2015","unstructured":"Meneses, M. et al. Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism. Curr. Pharm. Des. 21, 3606\u20133620 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"5137_CR10","doi-asserted-by":"publisher","unstructured":"Heidarisasan, S., Ziamajidi, N., Karimi, J. & Abbasalipourkabir, R. Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes. (2018). https:\/\/doi.org\/10.22038\/IJBMS.2018.28463.6899","DOI":"10.22038\/IJBMS.2018.28463.6899"},{"key":"5137_CR11","first-page":"571","volume":"36","author":"G Kalantarian","year":"2018","unstructured":"Kalantarian, G. et al. Effect of insulin-coated trimethyl Chitosan nanoparticles on IGF-1, IGF-2, and apoptosis in the hippocampus of diabetic male rats. Restor. Neurol. Neurosci. 36, 571\u2013581 (2018).","journal-title":"Restor. Neurol. Neurosci."},{"key":"5137_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2003.05.001","volume":"93","author":"A Bernkop-Schn\u00fcrch","year":"2003","unstructured":"Bernkop-Schn\u00fcrch, A., Kast, C. E. & Guggi, D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer\/gsh systems. J. Control Release. 93, 95\u2013103 (2003).","journal-title":"J. Control Release"},{"key":"5137_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.apsb.2018.01.013","volume":"8","author":"AM Wagner","year":"2018","unstructured":"Wagner, A. M., Gran, M. P. & Peppas, N. A. Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery. Acta Pharm. Sin B. 8, 147\u2013164 (2018).","journal-title":"Acta Pharm. Sin B"},{"key":"5137_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jphp.12852","volume":"70","author":"A Gedawy","year":"2018","unstructured":"Gedawy, A., Martinez, J., Al-Salami, H. & Dass, C. R. Oral insulin delivery: existing barriers and current counter-strategies. J. Pharm. Pharmacol. 70, 197\u2013213 (2018).","journal-title":"J. Pharm. Pharmacol."},{"key":"5137_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.nano.2014.02.014","volume":"10","author":"MA Lopes","year":"2014","unstructured":"Lopes, M. A. et al. Intestinal absorption of insulin nanoparticles: contribution of M cells. Nanomed. Nanatechnol. Biol. Med. 10, 1139\u20131151 (2014).","journal-title":"Nanomed. Nanatechnol. Biol. Med."},{"key":"5137_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpb.2020.08.001","volume":"155","author":"N Kamei","year":"2020","unstructured":"Kamei, N. et al. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin. Eur. J. Pharm. Biopharm. 155, 77\u201387 (2020).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"5137_CR17","first-page":"S434","volume":"11","author":"RS Hirlekar","year":"2017","unstructured":"Hirlekar, R. S., Patil, E. J. & Bhairy, S. R. Oral insulin delivery: novel strategies. Asian J. Pharm. 11, S434\u2013S443 (2017).","journal-title":"Asian J. Pharm."},{"key":"5137_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","volume":"447","author":"J Renukuntla","year":"2013","unstructured":"Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S. & Mitra, A. K. Approaches for enhancing oral bioavailability of peptides and proteins. Int. J. Pharm. 447, 75\u201393 (2013).","journal-title":"Int. J. Pharm."},{"key":"5137_CR19","doi-asserted-by":"publisher","unstructured":"Sonia, T. A. & Sharma, C. P. Oral delivery of insulin. Oral Deliv Insul. 1\u2013345. https:\/\/doi.org\/10.1016\/C2013-0-18177-9 (2015).","DOI":"10.1016\/C2013-0-18177-9"},{"key":"5137_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","volume":"484","author":"F Yu","year":"2015","unstructured":"Yu, F. et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int. J. Pharm. 484, 181\u2013191 (2015).","journal-title":"Int. J. Pharm."},{"key":"5137_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jconrel.2020.04.006","volume":"322","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Shrestha, N., Pr\u00e9at, V. & Beloqui, A. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. J. Control Release. 322, 486\u2013508 (2020).","journal-title":"J. Control Release"},{"key":"5137_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijpharm.2015.08.004","volume":"493","author":"H He","year":"2015","unstructured":"He, H., Wang, P., Cai, C., Yang, R. & Tang, X. VB12-coated Gel-Core-SLN containing insulin: another way to improve oral absorption. Int. J. Pharm. 493, 451\u2013459 (2015).","journal-title":"Int. J. Pharm."},{"key":"5137_CR23","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.xphs.2016.02.018","volume":"105","author":"M Boushra","year":"2016","unstructured":"Boushra, M. et al. Methocel-Lipid hybrid nanocarrier for efficient oral insulin delivery. J. Pharm. Sci. 105, 1733\u20131740 (2016).","journal-title":"J. Pharm. Sci."},{"key":"5137_CR24","unstructured":"Satyavani, K. & Gurudeeban, S. Insight on solid lipid nanoparticles: characterization and application in diabetes mellitus. J Crit. Rev 3, (2016)."},{"key":"5137_CR25","first-page":"1972","volume":"23","author":"MJ Ansari","year":"2016","unstructured":"Ansari, M. J. et al. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: Pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Deliv. 23, 1972\u20131979 (2016).","journal-title":"Drug Deliv"},{"key":"5137_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-12-391860-4.00015-X","volume":"508","author":"P Fonte","year":"2012","unstructured":"Fonte, P. et al. Chitosan-coated solid lipid nanoparticles for insulin delivery. Methods Enzymol. 508, 295\u2013314 (2012).","journal-title":"Methods Enzymol."},{"key":"5137_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jddst.2019.01.007","volume":"49","author":"M Boushra","year":"2019","unstructured":"Boushra, M., Tous, S., Fetih, G., Xue, H. Y. & Wong, H. L. Development of bi-polymer lipid hybrid nanocarrier (BLN) to improve the entrapment and stability of insulin for efficient oral delivery. J. Drug Deliv Sci. Technol. 49, 632\u2013641 (2019).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"5137_CR28","doi-asserted-by":"crossref","unstructured":"Koland, M., Anchan, R. B., Mukund, S. G. & Mulleria, S. S. Design and investigation of alginate coated solid lipid nanoparticles for oral insulin delivery. 55, 383\u2013394 (2021).","DOI":"10.5530\/ijper.55.2.76"},{"key":"5137_CR29","first-page":"297","volume":"13","author":"SY Eilleia","year":"2018","unstructured":"Eilleia, S. Y., Soliman, M. E., Mansour, S. & Geneidi, S. A. Novel technique of insulin loading into porous carriers for oral delivery. Asian J. Pharm. Sci. 13, 297\u2013309 (2018).","journal-title":"Asian J. Pharm. Sci."},{"key":"5137_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.10.006","volume":"313","author":"N Ji","year":"2019","unstructured":"Ji, N. et al. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo. J. Control Release. 313, 1\u201313 (2019).","journal-title":"J. Control Release"},{"key":"5137_CR31","doi-asserted-by":"crossref","unstructured":"Mumuni, M. A., Kenechukwu, F. C., Ofokansi, K. C., Attama, A. A. & D\u00edaz, D. D. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment. Carbohydr Polym 229, (2020).","DOI":"10.1016\/j.carbpol.2019.115506"},{"key":"5137_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","volume":"3","author":"K Kesarwani","year":"2013","unstructured":"Kesarwani, K. & Gupta, R. Bioavailability enhancers of herbal origin: an overview. Asian Pac. J. Trop. Biomed. 3, 253\u2013266 (2013).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"5137_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fitote.2014.05.005","volume":"97","author":"Ajazuddin","year":"2014","unstructured":"Ajazuddin et al. Role of herbal bioactives as a potential bioavailability enhancer for active pharmaceutical ingredients. Fitoterapia 97, 1\u201314 (2014).","journal-title":"Fitoterapia"},{"key":"5137_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1517\/17425255.2011.570332","volume":"7","author":"HK Han","year":"2011","unstructured":"Han, H. K. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin. Drug Metab. Toxicol. 7, 721\u2013729 (2011).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"5137_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.taap.2008.02.026","volume":"230","author":"Y Han","year":"2008","unstructured":"Han, Y., Tan, C., Lim, L. Y. & T. M. & In vitro and in vivo evaluation of the effects of Piperine on P-gp function and expression. Toxicol. Appl. Pharmacol. 230, 283\u2013289 (2008).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"5137_CR36","doi-asserted-by":"publisher","first-page":"07","DOI":"10.5530\/223097131736","volume":"13","author":"I Raghunath","year":"2022","unstructured":"Raghunath, I., Koland, M., Vadakkepushpakath, A. N., Kumar, L. & Shenoy, S. C. S. Herbal bioenhancers with nanocarriers: A promising approach for oral peptide delivery. Int. J. Pharm. Investig. 13, 07\u201313 (2022).","journal-title":"Int. J. Pharm. Investig"},{"key":"5137_CR37","doi-asserted-by":"publisher","first-page":"135849","DOI":"10.1016\/j.ijbiomac.2024.135849","volume":"280","author":"I Raghunath","year":"2024","unstructured":"Raghunath, I., Koland, M., Sarathchandran, C., Saoji, S. & Rarokar, N. Design and optimization of chitosan-coated solid lipid nanoparticles containing insulin for improved intestinal permeability using Piperine. Int. J. Biol. Macromol. 280, 135849. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135849 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"5137_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijpharm.2017.11.020","volume":"535","author":"N Jafary Omid","year":"2018","unstructured":"Jafary Omid, N. et al. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of Chitosan and trimethyl Chitosan nano-particles as carriers for oral insulin delivery. Int. J. Pharm. 535, 293\u2013307 (2018).","journal-title":"Int. J. Pharm."},{"key":"5137_CR39","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","volume":"30","author":"K Sonaje","year":"2009","unstructured":"Sonaje, K. et al. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30, 2329\u20132339 (2009).","journal-title":"Biomaterials"},{"key":"5137_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","volume":"440","author":"MR Rekha","year":"2013","unstructured":"Rekha, M. R. & Sharma, C. P. Oral delivery of therapeutic protein\/peptide for diabetes-Future perspectives. Int. J. Pharm. 440, 48\u201362 (2013).","journal-title":"Int. J. Pharm."},{"key":"5137_CR41","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1073\/pnas.1722338115","volume":"115","author":"A Banerjee","year":"2018","unstructured":"Banerjee, A. et al. Ionic liquids for oral insulin delivery. Proc. Natl. Acad. Sci. U S A. 115, 7296\u20137301 (2018).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"5137_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopha.2017.10.097","volume":"97","author":"M Jamshidi","year":"2018","unstructured":"Jamshidi, M., Ziamajidi, N., Khodadadi, I., Dehghan, A. & Kalantarian, G. Biomedicine & pharmacotherapy the e Ff Ect of insulin-loaded Trimethylchitosan nanoparticles on rats with diabetes type I. Biomed. Pharmacother. 97, 729\u2013735 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"5137_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF02913315","volume":"22","author":"A Akbarzadeh","year":"2007","unstructured":"Akbarzadeh, A. et al. Induction of diabetes by streptozotocin in rats. Indian J. Clin. Biochem. 22, 60\u201364 (2007).","journal-title":"Indian J. Clin. Biochem."},{"key":"5137_CR44","first-page":"402","volume":"4","author":"M Abdollahi","year":"2014","unstructured":"Abdollahi, M. & Hosseini, A. Streptozotocin. Encycl Toxicol. Third Ed. 4, 402\u2013404 (2014).","journal-title":"Encycl Toxicol. Third Ed."},{"key":"5137_CR45","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijbiomac.2020.01.302","volume":"149","author":"Y Kumari","year":"2020","unstructured":"Kumari, Y. et al. Modified Apple polysaccharide capped gold nanoparticles for oral delivery of insulin. Int. J. Biol. Macromol. 149, 976\u2013988 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"5137_CR46","doi-asserted-by":"publisher","first-page":"e03650","DOI":"10.1016\/j.heliyon.2020.e03650","volume":"6","author":"MA Momoh","year":"2020","unstructured":"Momoh, M. A. et al. Microemulsion-based approach for oral delivery of insulin: formulation design and characterization. Heliyon 6, e03650 (2020).","journal-title":"Heliyon"},{"key":"5137_CR47","doi-asserted-by":"publisher","first-page":"105179","DOI":"10.1039\/C5RA19115G","volume":"5","author":"AK Agrawal","year":"2015","unstructured":"Agrawal, A. K., Urimi, D., Harde, H., Kushwah, V. & Jain, S. Folate appended Chitosan nanoparticles augment the stability, bioavailability and efficacy of insulin in diabetic rats following oral administration. RSC Adv. 5, 105179\u2013105193 (2015).","journal-title":"RSC Adv."},{"key":"5137_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijbiomac.2020.11.190","volume":"167","author":"I Kaur","year":"2021","unstructured":"Kaur, I. et al. Exploring protein stabilized multiple emulsion with permeation enhancer for oral delivery of insulin. Int. J. Biol. Macromol. 167, 491\u2013501 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"5137_CR49","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/bm401580k","volume":"15","author":"AK Agrawal","year":"2014","unstructured":"Agrawal, A. K., Harde, H., Thanki, K. & Jain, S. Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. Biomacromolecules 15, 350\u2013360 (2014).","journal-title":"Biomacromolecules"},{"key":"5137_CR50","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1021\/acs.molpharmaceut.6b01099","volume":"14","author":"AK Agrawal","year":"2017","unstructured":"Agrawal, A. K., Kumar, K., Swarnakar, N. K., Kushwah, V. & Jain, S. Liquid crystalline nanoparticles\u2019: rationally designed vehicle to improve stability and therapeutic efficacy of insulin following oral administration. Mol. Pharm. 14, 1874\u20131882 (2017).","journal-title":"Mol. Pharm."},{"key":"5137_CR51","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1016\/j.xphs.2019.05.034","volume":"108","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. Design of Virus-Mimicking polyelectrolyte complexes for enhanced oral insulin delivery. J. Pharm. Sci. 108, 3408\u20133415 (2019).","journal-title":"J. Pharm. Sci."},{"key":"5137_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jsps.2018.01.010","volume":"26","author":"Y Baspinar","year":"2018","unstructured":"Baspinar, Y., \u00dcst\u00fcndas, M., Bayraktar, O. & Sezgin, C. Curcumin and Piperine loaded zein-chitosan nanoparticles: development and in-vitro characterisation. Saudi Pharm. J. 26, 323\u2013334 (2018).","journal-title":"Saudi Pharm. J."},{"key":"5137_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","volume":"1","author":"P Fonte","year":"2011","unstructured":"Fonte, P., Nogueira, T., Gehm, C., Ferreira, D. & Sarmento, B. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv Transl Res. 1, 299\u2013308 (2011).","journal-title":"Drug Deliv Transl Res."},{"key":"5137_CR54","doi-asserted-by":"crossref","unstructured":"Shalaby, T. I. & El-Refaie, W. M. Bioadhesive chitosan-coated cationic nanoliposomes with improved insulin encapsulation and prolonged oral hypoglycemic effect in diabetic mice. J. Pharm. Sci.\u00a0107 (2018).","DOI":"10.1016\/j.xphs.2018.04.011"},{"key":"5137_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5530\/jyp.2021.13.10","volume":"13","author":"RB Anchan","year":"2021","unstructured":"Anchan, R. B. & Koland, M. Oral insulin delivery by Chitosan coated solid lipid nanoparticles: ex vivo and in vivo studies. J. Young Pharm. 13, 43\u201348 (2021).","journal-title":"J. Young Pharm."},{"key":"5137_CR56","unstructured":"Chitosan, E. O. F., Solid, C., Nanoparticles, L., Oral, F. O. R. & Delivery, I. Development and Evaluation of Chitosan Coated Solid Lipid Nanoparticles for Oral. (1956)."},{"key":"5137_CR57","doi-asserted-by":"crossref","unstructured":"Weyers, M., Peterson, B., Hamman, J. H. & Steenekamp, J. H. Formulation of chitosan microparticles for enhanced intranasal macromolecular compound delivery: factors that influence particle size during ionic gelation. Gels 8\u00a0(2022).","DOI":"10.3390\/gels8110686"},{"key":"5137_CR58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0975-9476.65073","volume":"1","author":"N Atal","year":"2010","unstructured":"Atal, N., Bedi, K. L. & Bioenhancers Revolutionary concept to market. J. Ayurveda Integr. Med. 1, 96\u201399 (2010).","journal-title":"J. Ayurveda Integr. Med."},{"key":"5137_CR59","first-page":"1","volume":"2","author":"K K","year":"2018","unstructured":"K, K. Enhanced intestinal permeability of Silymarin by natural products as Bioenhancers - Assessment by Ex-Vivo noneverted rat gut sac study. Bioequivalence Bioavailab. Int. J. 2, 1\u201310 (2018).","journal-title":"Bioequivalence Bioavailab. Int. J."},{"key":"5137_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5599\/admet.3.1.161","volume":"3","author":"K Barve","year":"2015","unstructured":"Barve, K. & Ruparel, K. Effect of bioenhancers on amoxicillin bioavailability. ADMET DMPK. 3, 45\u201350 (2015).","journal-title":"ADMET DMPK"},{"key":"5137_CR61","first-page":"20","volume":"1","author":"SH Majumdar","year":"2018","unstructured":"Majumdar, S. H., Kulkarni, A. S., Kumbhar, S. M. & Bioenhancer, Y. Yogavahi - An ayurvedic concept used in modern medicines. Int. Res. J. Pharm. Med. Sci. 1, 20\u201325 (2018).","journal-title":"Int. Res. J. Pharm. Med. Sci."},{"key":"5137_CR62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/08982104.2021.1918153","volume":"32","author":"N Islam","year":"2022","unstructured":"Islam, N. et al. Piperine phytosomes for bioavailability enhancement of Domperidone. J. Liposome Res. 32, 172\u2013180 (2022).","journal-title":"J. Liposome Res."},{"key":"5137_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.04.136","author":"AAA Alsaad","year":"2022","unstructured":"Alsaad, A. A. A. Formulation & evaluation of \u03b2-glycyrrhetinic acid patches with natural bioenhancer. Mater. Today Proc. https:\/\/doi.org\/10.1016\/j.matpr.2021.04.136 (2022).","journal-title":"Mater. Today Proc."},{"key":"5137_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1515\/ntrev-2017-0151","volume":"6","author":"P Rathee","year":"2017","unstructured":"Rathee, P., Kamboj, A. & Sidhu, S. Enhanced oral bioavailability of nisoldipine-piperine-loaded poly-lactic-co-glycolic acid nanoparticles. Nanotechnol Rev. 6, 517\u2013526 (2017).","journal-title":"Nanotechnol Rev."},{"key":"5137_CR65","first-page":"1","volume":"4","author":"S Singh","year":"2021","unstructured":"Singh, S. & Piperine An effective bioenhancer for drug absorption. Pharm. Drug Regul. Aff J. 4, 1\u20133 (2021).","journal-title":"Pharm. Drug Regul. Aff J."},{"key":"5137_CR66","first-page":"35","volume":"14","author":"I Raghunath","year":"2024","unstructured":"Raghunath, I., Koland, M., Narayanan, A. V. & Piperine A possible permeation enhancer for oral protein delivery. J. Appl. Pharm. Sci. 14, 35\u201345 (2024).","journal-title":"J. Appl. Pharm. Sci."},{"key":"5137_CR67","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/193229681300700228","volume":"7","author":"P Fonte","year":"2013","unstructured":"Fonte, P., Ara\u00fajo, F., Reis, S. & Sarmento, B. Oral insulin delivery: how Far are we? J. Diabetes Sci. Technol. 7, 520\u2013531 (2013).","journal-title":"J. Diabetes Sci. Technol."},{"key":"5137_CR68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.peptides.2017.12.014","volume":"100","author":"S Rehmani","year":"2018","unstructured":"Rehmani, S. & Dixon, J. E. Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies. Peptides 100, 24\u201335 (2018).","journal-title":"Peptides"},{"key":"5137_CR69","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1742-1241.2010.02470.x","volume":"64","author":"S Arnolds","year":"2010","unstructured":"Arnolds, S., Kuglin, S., Kapitza, B., Heise, T. & C. & How Pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes. Int. J. Clin. Pract. 64, 1415\u20131424 (2010).","journal-title":"Int. J. Clin. Pract."},{"key":"5137_CR70","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1463-1326.2010.01343.x","volume":"13","author":"GB Bolli","year":"2011","unstructured":"Bolli, G. B. et al. Comparative pharmacodynamic and Pharmacokinetic characteristics of subcutaneous insulin Glulisine and insulin Aspart prior to a standard meal in obese subjects with type 2 diabetes. Diabetes Obes. Metab. 13, 251\u2013257 (2011).","journal-title":"Diabetes Obes. Metab."},{"key":"5137_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1078\/0944-7113-00114","volume":"9","author":"A Khajuria","year":"2002","unstructured":"Khajuria, A., Thusu, A., Zutshi, U. & N. & Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 9, 224\u2013231 (2002).","journal-title":"Phytomedicine"},{"key":"5137_CR72","first-page":"1283","volume":"7","author":"C Veeresham","year":"2012","unstructured":"Veeresham, C., Sajatha, S. & Rani, T. S. Effect of Piperine on the pharmacokinetics and pharmacodynamics of glimepiride in normal and streptozotocin-induced diabetic rats. Nat. Prod. Commun. 7, 1283\u20131286 (2012).","journal-title":"Nat. Prod. Commun."},{"key":"5137_CR73","doi-asserted-by":"publisher","first-page":"124764","DOI":"10.1016\/j.ijbiomac.2023.124764","volume":"242","author":"D Halarnekar","year":"2023","unstructured":"Halarnekar, D. et al. Eco synthesized chitosan\/zinc oxide nanocomposites as the next generation of nano-delivery for antibacterial, antioxidant, antidiabetic potential, and chronic wound repair. Int. J. Biol. Macromol. 242, 124764. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124764 (2023).","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05137-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:02:51Z","timestamp":1751421771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05137-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05137-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by IAEC (NGSMIPS\/IAEC\/JAN-2023\/333) and conducted according to the CPCSEA guidelines.\u00a0All of the experiments conducted on animals in this study received prior approval from the Institutional Animal Ethics Committee (IAEC), Institutional Animal Ethics Committee of the NGSM Institute of Pharmaceutical Sciences, Mangalore, India, and they followed the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) protocols.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There are no human subjects in this article and informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed consent"}},{"value":"All the authors have read and agreed to the final copy of the finding as contained in the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"22771"}}